BN83495 in Prostate Cancer
The purpose of the study is to evaluate the pharmacodynamic profile and safety of BN83495 in patients with prostate cancer with disease progression while on androgen ablative therapy
BN83495 in Prostate Cancer
- 23 October 2024 - 1 mins read
The purpose of the study is to evaluate the pharmacodynamic profile and safety of BN83495 in patients with prostate cancer with disease progression while on androgen ablative therapy
Related Clinical Trials
23 October 2024
1 mins read
Efficacy And Safety Of Dysport In The Treatment Of Upper Limb Spasticity In Children
23 October 2024
1 mins read
Dysport® Adult Upper Limb Spasticity Extension Study
23 October 2024
1 mins read
Safety and Efficacy Study of Dysport RU and Glabellar Lines
23 October 2024
1 mins read
Dysport® Adult Upper Limb Spasticity
23 October 2024
1 mins read
Study Comparing Short Term Efficacy of Dysport and Dysport NG to Placebo, and to Assess Efficacy and Safety of Dysport NG of Subjects With Cervical...
23 October 2024
1 mins read
Safety/Efficacy of Tigan® to Control Nausea/Vomiting Experienced During Apokyn® Initiation and Treatment
23 October 2024
1 mins read
Open-label Extension Study of AbobotulinumtoxinA (Dysport®) for the Treatment of Cervical Dystonia
23 October 2024
1 mins read
Study to Assess the Efficacy and Safety of Dysport® in Upper Back Myofascial Pain Syndrome
23 October 2024
1 mins read
Randomized, Placebo-Controlled Study of AbobotulinumtoxinA (Dysport®) for the Treatment of Cervical Dystonia
23 October 2024
1 mins read